Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MITF antibody (CF®647)

This anti-MITF antibody is a Rabbit Monoclonal antibody detecting MITF in IHC and IHC (fp). Suitable for Human and Dog.
Catalog No. ABIN7657104

Quick Overview for Recombinant MITF antibody (CF®647) (ABIN7657104)

Target

See all MITF Antibodies
MITF (Microphthalmia-Associated Transcription Factor (MITF))

Antibody Type

Recombinant Antibody

Reactivity

  • 116
  • 50
  • 27
  • 25
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Human, Dog

Host

  • 91
  • 43
  • 1
Rabbit

Clonality

  • 70
  • 65
Monoclonal

Conjugate

  • 72
  • 8
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This MITF antibody is conjugated to CF®647

Application

  • 76
  • 52
  • 50
  • 42
  • 37
  • 15
  • 13
  • 12
  • 12
  • 10
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

MITF-2987R
  • Purpose

    Microphthalmia Transcription Factor (MITF)(MITF/2987R), CF647 conjugate

    Characteristics

    MITF (microphthalmia transcription factor) is a basic helix-loop-helix-leucine-zipper (bHLH-Zip) transcription factor that regulates the development and survival of melanocytes and retinal pigment epithelium, and also is involved in transcription of pigmentation enzyme genes such as tyrosinase TRP1 and TRP2. MITF has been shown to be phosphorylated by MAP kinase in response to c-kit activation, resulting in upregulation of MITF transcriptional activity. Mutations of the MITF gene are associated with the autosomal dominant hereditary deafness and pigmentation condition, Waardenburg Syndrome type 2A. Multiple isoforms of MITF exist, including MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M, which differ in the amino-terminal domain and in their expression patterns. The MITF-M isoform is restricted to the melanocyte cell lineage. This MAb recognizes a nuclear protein, which is expressed in the majority of primary and metastatic epithelioid malignant melanomas as well as in normal melanocytes, benign nevi and dysplastic nevi. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant full-length human MiTF protein

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Positive Control: Jurkat, A-431, HeLa or 501 Mel human melanoma cells. Melanoma.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    MITF (Microphthalmia-Associated Transcription Factor (MITF))

    Alternative Name

    Microphthalmia Transcription Factor

    Background

    Synonyms: BHLHE32, Class E basic helix-loop-helix protein 32 (bHLHe32), CMM8, Mi, Microphthalmia-associated transcription factor, MITF, WS2, WS2A

    Gene Symbol: MITF

    Tissue Expression: Melanocytes

    Molecular Weight

    52-56 kDa (doublet)

    Gene ID

    4286

    UniProt

    O75030

    Pathways

    Chromatin Binding
You are here:
Chat with us!